ArticleNMR in biomedicine2026
Elbow Flexors Muscle Fat Fraction Is a Sensitive and Relevant Outcome Measure in Nonambulant Patients With DMD.
Article in NMR in biomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Duchenne muscular dystrophy (DMD) is an X-linked neuromuscular disease characterized by progressive muscle wasting. Objective and relevant outcome measures are needed for longitudinal follow-up and clinical trials. Quantitative MR muscle parameters in the legs are sensitive to change and related to function. However, data are limited for the upper limb, which is crucial for nonambulant DMD patients. This study investigated which MR parameters were sensitive to change over time and associated with loss of upper limb function. Muscle fat fraction (mFF) and contractile volume (CV) for elbow flexor and extensor muscles were obtained using chemical-shift-based fat-water separation scans at 3T (Philips, Ingenia) at baseline, 12, and 18 months. Standardized response means (SRM) were determined for different analysis volumes: center slice (CS), 5 (5S), 7 (7S), and all slices (AS). Parameters with SRM > 0.8 were associated with Performance of the Upper Limb, PUL2.0, using linear mixed models. Twenty nonambulant DMD patients participated. Baseline mFF ranged between 43.1% ± 12.6% for elbow extensors AS and 55.5% ± 18.9% for elbow flexors CS. SRM ranged from 0.37 for elbow flexors CV CS to 1.71 for elbow flexors AS and was consistently higher for increasing analysis volumes, longer follow-up time, and for mFF in comparison with CV. Associations with function were significant for all parameters and ranged from -0.25 to -0.34 (p < 0.001) for mFF and 0.12-0.49 (p < 0.001) for CV, except for elbow extensor CS CV (p = 0.87). Our study demonstrates that assessment of a larger part of the muscle increases the sensitivity to change over time in nonambulant DMD patients. Elbow flexor and extensor mFF 5S, 7S, and AS were sensitive to change over 12 months and related to loss of upper limb function in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.